WinCap Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
23,756
+1,612
+7% +$92.6K 0.74% 35
2026
Q1
$1.34M Buy
22,144
+1,693
+8% +$98.7K 0.89% 29
2025
Q4
$1.1M Buy
20,451
+437
+2% +$21K 0.76% 35
2025
Q3
$903K Buy
20,014
+632
+3% +$29.5K 0.62% 44
2025
Q2
$897K Buy
19,382
+2,026
+12% +$99.5K 0.72% 42
2025
Q1
$1.06M Buy
17,356
+592
+4% +$34.5K 1% 32
2024
Q4
$948K Buy
+16,764
New +$937K 0.97% 35

Other funds holding BMY

WinCap Financial's BMY Position: Q2 2026 in Review

WinCap Financial increased its Bristol-Myers Squibb (BMY) stake by 7.3% in Q2 2026, buying an estimated $92.6K and bringing the position to 23,756 shares worth $1.37M. The position accounts for 0.74% of the portfolio, ranked #35.

WinCap Financial first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • WinCap Financial held 23,756 shares of Bristol-Myers Squibb worth $1.37M as of Q2 2026.
  • WinCap Financial bought 1,612 Bristol-Myers Squibb shares in Q2 2026, an estimated $92.6K.
  • Bristol-Myers Squibb made up 0.74% of WinCap Financial's portfolio in Q2 2026, its #35 holding.
  • WinCap Financial first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on WinCap Financial's 13F filing for Q2 2026, filed 9 Jul 2026.